https://www.selleckchem.com/pr....oducts/NVP-BHG712.ht
spite effective neuroinflammation suppression, may explain CBA- and SIV-associated neurocognitive deficits. Therapeutics targeting growth factor signaling may be important adjuvants in treating HIV-associated neurocognitive decline. To determine the clinical metrics of functional assessments in pediatric critical illness survivors. Cross-sectional observational study. PICU follow-up clinic. Forty-four PICU survivors 6-12 months post PICU stay, and 52 healthy controls 0-18 years old. Nil. Function was assessed using the Pediatric Qual
Like
Comment
Share
